PENTOXIL Drug Patent Profile
✉ Email this page to a colleague
When do Pentoxil patents expire, and what generic alternatives are available?
Pentoxil is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in PENTOXIL is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentoxil
A generic version of PENTOXIL was approved as pentoxifylline by ANI PHARMS on July 9th, 1997.
Summary for PENTOXIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PENTOXIL at DailyMed |
Recent Clinical Trials for PENTOXIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
Mayo Clinic | Phase 3 |
National Institute of Mental Health (NIMH) | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for PENTOXIL
US Patents and Regulatory Information for PENTOXIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upsher Smith Labs | PENTOXIL | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074962-001 | Mar 31, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |